Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Vesprini

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 31, 2016
Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate CancerHima Bindu Musunuru, Melanie Davidson, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2023
Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastasesEric K Nguyen, Renee Korol, Saher Ali, et al.
Breast Cancer Research and Treatment|January 12, 2011
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriersKelly Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
Clinical and Translational Radiation Oncology|September 25, 2024
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trialsRachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Oncotarget|December 1, 2016
Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancerAlireza Fotouhi Ghiam, Samira Taeb, Xiaoyong Huang, et al.
Oncotarget|June 25, 2019
<i>A priori</i> prediction of breast tumour response to chemotherapy using quantitative ultrasound imaging and artificial neural networksHadi Tadayyon, Mehrdad Gangeh, Lakshmanan Sannachi, et al.
JAMA Oncology|May 26, 2022
Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size: A Randomized Clinical TrialDanny Vesprini, Melanie Davidson, Sandi Bosnic, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2023
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT)Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
European Urology|July 19, 2018
Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective TrialLaurence Klotz, Andrew Loblaw, Linda Sugar, et al.
Pathology, Research and Practice|August 30, 2020
Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutationsAnjelica Hodgson, Bas W G van Rhijn, Sung Sun Kim, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|March 31, 2016
Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate CancerHima Bindu Musunuru, Melanie Davidson, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2023
Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastasesEric K Nguyen, Renee Korol, Saher Ali, et al.
Breast Cancer Research and Treatment|January 12, 2011
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriersKelly Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
Clinical and Translational Radiation Oncology|September 25, 2024
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trialsRachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Oncotarget|December 1, 2016
Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancerAlireza Fotouhi Ghiam, Samira Taeb, Xiaoyong Huang, et al.
Oncotarget|June 25, 2019
<i>A priori</i> prediction of breast tumour response to chemotherapy using quantitative ultrasound imaging and artificial neural networksHadi Tadayyon, Mehrdad Gangeh, Lakshmanan Sannachi, et al.
JAMA Oncology|May 26, 2022
Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size: A Randomized Clinical TrialDanny Vesprini, Melanie Davidson, Sandi Bosnic, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2023
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT)Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
European Urology|July 19, 2018
Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective TrialLaurence Klotz, Andrew Loblaw, Linda Sugar, et al.
Pathology, Research and Practice|August 30, 2020
Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutationsAnjelica Hodgson, Bas W G van Rhijn, Sung Sun Kim, et al.
Pageof 15